/Investor DB

Auriga Partners

Venture capital

Parent of1 affiliated firmScientipole Ile-de-France Capital

Paris · Seed–Growth · 16 people tracked

Also known as Auriga

Find your way into Auriga Partners

Sign up to see every warm intro you have to Auriga Partners

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Auriga Partners team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Auriga Partners is a pioneer of venture capital in France that has reinvented itself as a multi-specialist investor aiming to bring together specific expertise around forward-looking themes and territories, investing in both private and public companies. The firm supports entrepreneurs at every stage of their development, from creation through to exit via trade sale or IPO. It emphasizes the power of innovation—whether in usage or disruptive—to catalyze positive change for lives and societies, and leverages collective intelligence built from federating talent and expertise across future-oriented themes.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Growth
Check
$540K – $5.4M
HQ
Paris, FR
Instruments
Equity
Founded
1998
AUM
$469.8M
Tracked investments
20
Acquisitions
1

Team · 16 people

from the firm's website & public directories
Bastien Menguy· Senior Principal (Auriga Cyber Ventures)in
Marion VEDRENNE· Accounting Assistantin

Accounting Assistant who supports the Accounting Manager's tasks.

What they invest in

from 10 of 20 portfolio companies

Cybersecurity ×6AI & Machine Learning ×5Deep Tech ×4Data & Infrastructure ×3Developer Tools ×3Biotech ×2Cloud Computing ×2Enterprise Software ×2

HQs:France×3United States×2Germany×1United Kingdom×1Netherlands×1

Investments · 20 tracked

founders shown can be your intro path

By year:2024 · 12023 · 12013 · 12010 · 12004 · 15 dated

Skyldskyld.io✓ verified

Skyld provides protection for on-device and edge AI models against reverse engineering, model extraction, and adversarial attacks, helping companies secure their intellectual property and deploy models safely.

AI & Machine LearningCybersecurityDeep Tech

Marie Paindavoine(Founder & CEO)

Co-investorsSodero

Codenvycodenvy.comin𝕏Feb 2013 · $9Macquired by Red Hat

Red Hat provides developer tools for building applications on Kubernetes and OpenShift, focusing on cloud-native development workflows with reduced friction from code to production.

AI & Machine LearningCloud ComputingDeveloper Tools

Co-investorsHeavybitToba CapitalXAnge

Cytixcytix.io

Cytix is a security platform that analyzes individual software changes—tickets, pull requests, code diffs and policies—to assess their risk, prioritize high-risk changes, auto-approve low-risk ones, and validate risks through a multi-agent testing framework.

AI & Machine LearningCybersecurityDeveloper ToolsManchester, GB

Harry Hance(Founder)

Enclaiveenclaive.ioin𝕏

enclaive provides a multi-cloud platform for Confidential Computing, using hardware-based Trusted Execution Environments to keep applications, databases, and AI workloads encrypted in use so that only the customer holds the keys.

Cloud ComputingCybersecurityData & InfrastructureDeep Tech

GajekSebastian Gajek(Founder)

Co-investorsAPEX VenturesF-TechnologiesJoin Capital

Exeliom Biosciencesexeliombio.cominJul 2023

Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis).

BiotechDeep TechDigital HealthMedical DevicesParis, FR

Harry Sokol(Scientific Co-founder)in

Co-investorsBpifranceAgoranovForepont Capital PartnersUI Investissement

Genocea Biosciencesin

Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.

BiotechCambridge, US

Narinder Singh(Executive Officer)Derek Meisner(Executive Officer)inMichael Alfieri(Executive Officer)Jessica Flechtner(Executive Officer)Girish Aakalu(Executive Officer)Thomas Davis(Executive Officer)

Co-investorsCycad Group LLCLux CapitalMC Healthcare VenturesAdvent Life SciencesAlexandriaBill & Melinda Gates Foundation+1 more

Implanetimplanet.cominApr 2010 · $11M

Implanet designs and manufactures spinal implants for surgeons specializing in spine surgery, operating as an international publicly listed medical device company with presence in 42 countries.

HardwareMedical DevicesBordeaux, FR

Co-investorsAndera PartnersM Capital Partners

Median Technologiesmediantechnologies.comSeries B · Nov 2004 · $5M
Mithril Securitymithrilsecurity.ioin𝕏

Mithril Security builds a secure supply chain for AI providers, offering provenance traceability, model protection, and data confidentiality.

AI & Machine LearningCybersecurityDeep Tech

Co-investorsIT-Farm CorporationPolytechnique VenturesSTATION F

Nymiznymiz.comApr 2024

Nymiz provides automated data anonymization and pseudonymization software for law firms and legal operations, using AI-driven techniques to redact personal information across unstructured documents and databases while preserving data utility.

AI & Machine LearningCybersecurityData & InfrastructureEnterprise SoftwareLegalTech

Oscar Villanueva Cañizares(Founder)inManuel Diaz(Founder)in

Co-investorsSwanlaab Venture FactoryTIIN CapitalCDTIGoHub Ventures

Virtualmetricvirtualmetric.comin

VirtualMetric provides a security data pipeline platform that helps organizations manage their security telemetry, optimize SIEM costs, and handle log management for compliance.

CybersecurityData & InfrastructureDeveloper ToolsEnterprise SoftwareNetherlands, NL

Yusuf Ozturk(Founder)in

Co-investorsTIIN Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AerAccessAlgentechAmoebaCryptonextDowsersGalinkPeripherySensityTremau

Exits · 1

1 acquisitions

Codenvyacq. by Red Hat

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Auriga Partners made?
Auriga Partners has 20 tracked investments, 1 of which have exited.
What stage does Auriga Partners invest at?
Auriga Partners invests at the Seed, Series A, Series B, Growth stages.
What is Auriga Partners's typical check size?
Auriga Partners typically writes checks of $540K – $5.4M.
What sectors does Auriga Partners focus on?
Auriga Partners focuses on Biotech, Consumer, Cybersecurity, Data & Infrastructure, Enterprise Software, Hardware, Healthtech, Longevity, Medical Devices, New Materials, SaaS, Sector Agnostic.
Where is Auriga Partners located?
Auriga Partners is headquartered in Paris, FR.

Funds & brands

Separately branded funds and arms of Auriga Partners. Each has its own page; people who work on a brand are listed on both.

Similar investors

Featured in lists